Malcisbo AG

Swiss Biotech Association

Member
Claim / update listing

Malcisbo is specialized on glycoengineering technologies to develop novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Our platform technology provides a tool to develop a strong pipeline of novel, cost-efficient vaccine products.

http://www.malcisbo.com

Location

Wagistrasse 27a, 8952 Schlieren, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2010
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Solvias AG

Solvias is a contract research, development & manufacturing
We offer early phase development of small molecules API by process R&D and GMP-manufacturing integrated with high through-put screening, solid state and a wide ligand portfolios for catalytic transformations and analytical services.
Kaiseraugst

Member

Porton Pharmaceutical Chemicals GmbH

Porton Pharma is a a leading CDMO with operations and commercial offices across the US, EU and China. Porton Pharma provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecules, dosage forms and biologics.
6039 Root

Member

Bavarian Nordic Berna GmbH

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
3174 Thörishaus

Member